| Application no. and date | 03706732.9 (espacenet) (Federated) (European Patent Register), 20030224 | | Patent/reg. no. and date | DK/EP 1480679, 20070523 | | Publication date | 20041201 | | Priority no. and date | GB 0204392, 20020226, GB 0212462, 20020530, GB 0213267, 20020611 | | EP pub. no. and date |
EP 1480679 20041201 | | Effective date | | | Applicant/owner | Astrazeneca AB, S-151 85 Sodertalje, SE | | Applicant ref. no. | | | Inventor | GELLERT, Paul Richard, AstraZeneca R & D Alderley,
Alderley Park
Macclesfield,
Cheshire SK10 4TG, GB,
PARKER, Michael Davis, AstraZeneca,
Charter Way
Macclesfield,
Cheshire SK10 2NA, GB,
DE MATAS, Marcel, AstraZeneca R & D Alderley,
Alderley Park
Macclesfield,
Cheshire SK10 4TG, GB | | Representative | | | Opponent | | | IPC Class | A61K 31/5377 (2006.01) , A61K 47/38 (2006.01) , A61P 35/00 (2006.01) | | Title | Farmaceutisk formulering af iressa, der omfatter et vandopløseligt cellulosederivat | | Int. application no. | GB2003000803 | | Int. publication no. | WO2003072139 | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
